Search results

From Self-sufficiency
Jump to: navigation, search
  • ...or '''Zantac''') is a [[histamine]] [[H2-receptor antagonist|H<sub>2</sub>-receptor antagonist]] that inhibits [[gastric acid|stomach acid]] production. It is {{Main|H2-receptor antagonist}}
    5 KB (699 words) - 16:49, 27 September 2010
  • ...short-acting [[beta2-adrenergic receptor agonist|β<sub>2</sub>-adrenergic receptor agonist]] used for the relief of [[bronchospasm]] in conditions such as [[a Salbutamol was the first selective Β2-receptor agonist to be marketed — in 1968. It was first sold by Allen & Hanburys u
    15 KB (2,005 words) - 16:49, 27 September 2010
  • ...tion]] and [[mucus]] [[secretion]]. It is a non-selective [[muscarinic]] [[Receptor antagonist|antagonist]], and does not diffuse into the blood, which prevent [[pt:Ipratrópio]]
    5 KB (580 words) - 16:49, 27 September 2010
  • ...or|5-HT<sub>3</sub> receptor]] antagonist/[[5-HT receptor|5-HT<sub>4</sub> receptor]] agonist. ...activity, D<sub>2</sub> receptor antagonist activity and 5-HT<sub>4</sub> receptor agonist activity.<ref name="Martindale34">Sweetman S, editor. Martindale: T
    11 KB (1,453 words) - 16:49, 27 September 2010
  • ...s Type I and Type II receptor agonist), or [[RU28362]] (a specific Type II receptor agonist), to adrenalectomized animals induced changes in [[leukocyte distri .... Aldosterone and cortisol have similar affinity for the mineralocorticoid receptor however, glucocorticoids circulate at roughly 100 times the level of minera
    41 KB (5,644 words) - 16:50, 27 September 2010
  • {{See also|Adrenergic receptor}} ...ues. Its actions vary by tissue type and tissue expression of [[adrenergic receptor]]s. For example, epinephrine causes [[smooth muscle]] relaxation in the air
    22 KB (2,916 words) - 16:50, 27 September 2010
  • ...= 1095–101|year = 2000|pmid = 11020766|url = http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0003-3022&volum ...7862891}}</ref> Indeed, in humans given 30% N<sub>2</sub>O, benzodiazepine receptor antagonists reduced the subjective reports of feeling "high", but did not a
    61 KB (8,728 words) - 16:50, 27 September 2010
  • ...that apparently only reacted to morphine: the mu3 [[Opioid receptor|opiate receptor]] in human tissue.<ref>{{cite journal |author=Zhu W, Cadet P, Baggerman G, ...morphine|journal=Journal of Physiology and Pharmacology|volume=55|issue=1 Pt 2|pages=279–288|date=March 2004|pmid=15082884|last2=Zhu|first2=W|last3=Ca
    87 KB (12,376 words) - 16:51, 27 September 2010
  • ...in receptor (nociceptor) of the body, the [[TRPV1]] (older name: vanilloid receptor). Furthermore, AM404 inhibits sodium channels, as do the anesthetics lidoca <!--{{Link FA|pt}}http://pt.wikipedia.org/wiki/Wikipedia:Revalida%C3%A7%C3%A3o/Paracetamol-->
    54 KB (7,376 words) - 16:52, 27 September 2010
  • ...''The Sympathomimetic Actions of l-Ephedrine and d-Pseudoephedrine: Direct Receptor Activation or Norepinephrine Release?''] Anesth Analg 2003; 97, pp.1239-124 ...ochemistry|steric]] orientation of the [[hydroxyl]] group is important for receptor binding and functional activity.<ref name='Ma'/>
    21 KB (2,906 words) - 16:51, 27 September 2010
  • ...inding to the benzodiazepine site on the [[GABAA receptor|GABA<sub>A</sub> receptor]] leading to [[central nervous system]] depression.<ref name="Riss-2008"/> ...irst2 = R. | last3 = Hösl | first3 = K. | title = Subtype-selective GABAA receptor mimetics--novel antihyperalgesic agents? | url = http://www.springerlink.co
    78 KB (10,295 words) - 16:51, 27 September 2010
  • ...d]] (GABA) [[receptor antagonist]]. Cicutoxin acts on the GABA<sub>A</sub> receptor causing a block of the [[chloride channel]] which results in [[neuronal dep [[pt:Cicuta]]
    29 KB (4,114 words) - 12:26, 7 July 2010
  • ...nn M"/> 3) Surface enterocytes also express high levels of [[Interleukin-1 receptor]] (IL-1R) -containing inhibitory molecule. IL-1R are also referred to as si ...mponent that monitors and responds to changes in the environment. When the receptor senses a stimulus, it sends information to a '''control center''', the comp
    21 KB (3,070 words) - 21:41, 19 September 2010
  • ...oscyamine]], and [[scopolamine]] antagonize the [[muscarinic acetylcholine receptor|muscarinic acetylcholine]] receptors in the eye. By blocking these receptor [[pt:Midríase]]
    9 KB (1,223 words) - 09:40, 20 September 2010
  • # nonselective [[adenosine receptor]] antagonist <ref name="AR-Daly">{{cite journal | author=Daly JW, Jacobson [[pt:Pentoxifilina]]
    7 KB (885 words) - 09:43, 20 September 2010
  • '''Tasosartan''' is an [[angiotensin II receptor antagonist]]. ...}}</ref><ref>{{cite journal |author=Dina R, Jafari M |title=Angiotensin II-receptor antagonists: an overview |journal=Am J Health Syst Pharm |volume=57 |issue=
    2 KB (250 words) - 09:44, 20 September 2010
  • ...ncrease Thyroid Hormone Levels via Down-Regulation of the Aryl Hydrocarbon Receptor (AhR) Target Gene UDP-Glucuronosyltransferase|journal=Environmental Health [[pt:Poliestireno]]
    36 KB (5,017 words) - 10:14, 20 September 2010
  • ...ib''' (trade name '''Votrient''') is a potent and selective multi-targeted receptor [[tyrosine kinase inhibitor]] of [[VEGFR]]-1, VEGFR-2, VEGFR-3, [[PDGFR]]-a [[pt:Pazopanib]]
    3 KB (324 words) - 13:12, 20 September 2010
  • ...imic the molecular shape of [[adrenaline]]. It binds to [[alpha-adrenergic receptor]]s in the nasal mucosa.<ref>{{cite pmid|20030735}}</ref> Due to its [[sympa [[pt:Xilometazolina]]
    3 KB (395 words) - 13:14, 20 September 2010
  • ...ts action on the [[D2 receptor|D2 dopamine]] and [[5HT1A|5-HT<sub>1A</sub> receptor]]s that can cause some side effects. <ref name="Tfelt">{{cite journal|autho [[pt:Ergotamina]]
    7 KB (986 words) - 13:14, 20 September 2010

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)